Interaction of a putative BH3 domain of clusterin with anti-apoptotic Bcl-2 family proteins as revealed by NMR spectroscopy

Biochemical and Biophysical Research Communications

Volumn 408, Issue 4, 2011, Pages 541-547

  Lee, Dong Hwa ^a   Ha, Ji Hyang ^a   Kim, Yul ^b   Bae, Kwang Hee ^a   Park, Jae Yong ^c   Choi, Wan Sung ^c   Yoon, Ho Sup ^d   Park, Sung Goo ^a   Park, Byoung Chul ^a   Yi, Gwan Su ^b   Chi, Seung Wook ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

^c Gyeongsang National University School of Medicine   (South Korea)

^d NANYANG TECHNOLOGICAL UNIVERSITY   (Singapore)

Author keywords

Apoptosis; Bcl 2 family protein; BH3 domain; Clusterin; NMR

Indexed keywords

BH3 PROTEIN; CLUSTERIN; PROTEIN BCL 2; PROTEIN BCL X;

ARTICLE; MOLECULAR INTERACTION; MUTATIONAL ANALYSIS; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; SEQUENCE ANALYSIS;

AMINO ACID SEQUENCE; APOPTOSIS; ASPARTIC ACID; CELL NUCLEUS; CLUSTERIN; HUMANS; LEUCINE; MOLECULAR SEQUENCE DATA; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN STRUCTURE, TERTIARY; PROTO-ONCOGENE PROTEINS C-BCL-2;

EID: 79956213385     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.04.054     Document Type: Article

References (32)

1. Gleave M., Jansen B. Clusterin and IGFBPs as antisense targets in prostate cancer. Ann. NY Acad. Sci. 2003, 1002:95-104.
2. Trougakos I.P., Gonos E.S. Clusterin/apolipoprotein J in human aging and cancer. Int. J. Biochem. Cell Biol. 2002, 34:1430-1448.
3. Moretti R.M., Marelli M.M., Mai S., Cariboni A., Scaltriti M., Bettuzzi S., Limonta P. Clusterin isoforms differentially affect growth and motility of prostate cells: possible implications in prostate tumorigenesis. Cancer Res. 2007, 67:10325-10333.
4. Shannan B., Seifert M., Leskov K., Willis J., Boothman D., Tilgen W., Reichrath J. Challenge and promise: roles for clusterin in pathogenesis, progression and therapy of cancer. Cell Death Differ. 2006, 13:12-19.
5. Trougakos I.P., So A., Jansen B., Gleave M.E., Gonos E.S. Silencing expression of the clusterin/apolipoprotein J gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res. 2004, 64:1834-1842.
6. Miyake H., Hara I., Kamidono S., Gleave M.E., Eto H. Resistance to cytotoxic chemotherapy-induced apoptosis in human prostate cancer cells is associated with intracellular clusterin expression. Oncol. Rep. 2003, 10:469-473.
7. Trougakos I.P., Djeu J.Y., Gonos E.S., Boothman D.A. Advances and challenges in basic and translational research on clusterin. Cancer Res. 2009, 69:403-406.
8. Bettuzzi S., Scorcioni F., Astancolle S., Davalli P., Scaltriti M., Corti A. Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression. Oncogene 2002, 21:4328-4334.
9. Leskov K.S., Klokov D.Y., Li J., Kinsella T.J., Boothman D.A. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J. Biol. Chem. 2003, 278:11590-11600.
10. Trougakos I.P., Gonos E.S. Regulation of clusterin/apolipoprotein J, a functional homologue to the small heat shock proteins, by oxidative stress in ageing and age-related diseases. Free Radic. Res. 2006, 40:1324-1334.
11. Trougakos I.P., Lourda M., Antonelou M.H., Kletsas D., Gorgoulis V.G., Papassideri I.S., Zou Y., Margaritis L.H., Boothman D.A., Gonos E.S. Intracellular clusterin inhibits mitochondrial apoptosis by suppressing p53-activating stress signals and stabilizing the cytosolic Ku70-Bax protein complex. Clin. Cancer Res. 2009, 15:48-59.
12. Zhang H., Kim J.K., Edwards C.A., Xu Z., Taichman R., Wang C.Y. Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 2005, 7:909-915.
13. Yang C.R., Leskov K., Hosley-Eberlein K., Criswell T., Pink J.J., Kinsella T.J., Boothman D.A. Nuclear clusterin/XIP8, an X-ray-induced Ku70-binding protein that signals cell death. Proc. Natl. Acad. Sci. USA 2000, 97:5907-5912.
14. Scaltriti M., Santamaria A., Paciucci R., Bettuzzi S. Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells. Cancer Res. 2004, 64:6174-6182.
15. Takase O., Minto A.W., Puri T.S., Cunningham P.N., Jacob A., Hayashi M., Quigg R.J. Inhibition of NF-kappaB-dependent Bcl-xL expression by clusterin promotes albumin-induced tubular cell apoptosis. Kidney Int. 2008, 73:567-577.
16. Youle R.J., Strasser A. The BCL-2 protein family: opposing activities that mediate cell death. Nat. Rev. Mol. Cell Biol. 2008, 9:47-59.
17. Kelekar A., Thompson C.B. Bcl-2-family proteins: the role of the BH3 domain in apoptosis. Trends Cell Biol. 1998, 8:324-330.
18. Lomonosova E., Chinnadurai G. BH3-only proteins in apoptosis and beyond: an overview. Oncogene 2008, 27(Suppl. 1):S2-S19.
19. Liu Z., Lu H., Jiang Z., Pastuszyn A., Hu C.A. Apolipoprotein l6, a novel proapoptotic Bcl-2 homology 3-only protein, induces mitochondria-mediated apoptosis in cancer cells. Mol. Cancer Res. 2005, 3:21-31.
20. Sinha S., Levine B. The autophagy effector Beclin 1: a novel BH3-only protein. Oncogene 2008, 27(Suppl. 1):S137-S148.
21. Day C.L., Smits C., Fan F.C., Lee E.F., Fairlie W.D., Hinds M.G. Structure of the BH3 domains from the p53-inducible BH3-only proteins Noxa and Puma in complex with Mcl-1. J. Mol. Biol. 2008, 380:958-971.
22. Sigrist C.J., Cerutti L., de Castro E., Langendijk-Genevaux P.S., Bulliard V., Bairoch A., Hulo N. PROSITE, a protein domain database for functional characterization and annotation. Nucleic Acids Res. 2010, 38:D161-D166.
23. Edgar R.C. MUSCLE: multiple sequence alignment with high accuracy and high throughput. Nucleic Acids Res. 2004, 32:1792-1797.
24. Eddy S.R. Profile hidden Markov models. Bioinformatics 1998, 14:755-763.
25. Petros A.M., Medek A., Nettesheim D.G., Kim D.H., Yoon H.S., Swift K., Matayoshi E.D., Oltersdorf T., Fesik S.W. Solution structure of the antiapoptotic protein bcl-2. Proc. Natl. Acad. Sci. USA 2001, 98:3012-3017.
26. Sattler M., Liang H., Nettesheim D., Meadows R.P., Harlan J.E., Eberstadt M., Yoon H.S., Shuker S.B., Chang B.S., Minn A.J., Thompson C.B., Fesik S.W. Structure of Bcl-xL-Bak peptide complex: recognition between regulators of apoptosis. Science 1997, 275:983-986.
27. Delaglio F., Grzesiek S., Vuister G.W., Zhu G., Pfeifer J., Bax A. NMRPipe: a multidimensional spectral processing system based on UNIX pipes. J. Biomol. NMR 1995, 6:277-293.
28. Goddard T.D., Kneller D.G. SPARKY 2003, University of California, San Francisco.
29. Dominguez C., Boelens R., Bonvin A.M. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 2003, 125:1731-1737.
30. Petros A.M., Nettesheim D.G., Wang Y., Olejniczak E.T., Meadows R.P., Mack J., Swift K., Matayoshi E.D., Zhang H., Thompson C.B., Fesik S.W. Rationale for Bcl-xL/Bad peptide complex formation from structure, mutagenesis, and biophysical studies. Protein Sci. 2000, 9:2528-2534.
31. Liu X., Dai S., Zhu Y., Marrack P., Kappler J.W. The structure of a Bcl-xL/Bim fragment complex: implications for Bim function. Immunity 2003, 19:341-352.
32. Stoll R., Renner C., Hansen S., Palme S., Klein C., Belling A., Zeslawski W., Kamionka M., Rehm T., Muhlhahn P., Schumacher R., Hesse F., Kaluza B., Voelter W., Engh R.A., Holak T.A. Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53. Biochemistry 2001, 40:336-344.